BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17210976)

  • 21. Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa.
    Lawn SD; Bangani N; Vogt M; Bekker LG; Badri M; Ntobongwana M; Dockrell HM; Wilkinson RJ; Wood R
    BMC Infect Dis; 2007 Aug; 7():99. PubMed ID: 17725839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection.
    Mazurek GH; LoBue PA; Daley CL; Bernardo J; Lardizabal AA; Bishai WR; Iademarco MF; Rothel JS
    JAMA; 2001 Oct; 286(14):1740-7. PubMed ID: 11594899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study.
    Goletti D; Carrara S; Mayanja-Kizza H; Baseke J; Mugerwa MA; Girardi E; Toossi Z
    BMC Infect Dis; 2008 Jan; 8():11. PubMed ID: 18226199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profile of interferon-gamma response to latency-associated and novel in vivo expressed antigens in a cohort of subjects recently exposed to Mycobacterium tuberculosis.
    Araujo LS; da Silva NBM; da Silva RJ; Leung JAM; Mello FCQ; Saad MHF
    Tuberculosis (Edinb); 2015 Dec; 95(6):751-757. PubMed ID: 26421415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette-Guérin-vaccinated Individuals.
    Peña D; Rovetta AI; Hernández Del Pino RE; Amiano NO; Pasquinelli V; Pellegrini JM; Tateosian NL; Rolandelli A; Gutierrez M; Musella RM; Palmero DJ; Gherardi MM; Iovanna J; Chuluyan HE; García VE
    EBioMedicine; 2015 Aug; 2(8):884-90. PubMed ID: 26425695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
    Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
    Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
    Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test.
    Diel R; Ernst M; Döscher G; Visuri-Karbe L; Greinert U; Niemann S; Nienhaus A; Lange C
    Eur Respir J; 2006 Jul; 28(1):16-23. PubMed ID: 16481383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycobacterium tuberculosis epitope-specific interferon-g production in healthy Brazilians reactive and non-reactive to tuberculin skin test.
    Silva BC; Grassi MF; Coutinho R; Mascarenhas RE; Olavarria VN; Coutinho-Borgo A; Kalil J; Cunha Neto E; Fonseca SG
    Mem Inst Oswaldo Cruz; 2014 Dec; 109(8):999-1004. PubMed ID: 25494469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis.
    Chiappini E; Della Bella C; Bonsignori F; Sollai S; Amedei A; Galli L; Niccolai E; Del Prete G; Singh M; D'Elios MM; de Martino M
    PLoS One; 2012; 7(9):e46041. PubMed ID: 23029377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis.
    Goletti D; Raja A; Ahamed Kabeer BS; Rodrigues C; Sodha A; Butera O; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH
    J Infect; 2010 Jul; 61(2):133-43. PubMed ID: 20470822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of gamma interferon release assays using Mycobacterium tuberculosis antigens for diagnosis of latent and active tuberculosis in Mycobacterium bovis BCG-vaccinated populations.
    Zhang S; Shao L; Mo L; Chen J; Wang F; Meng C; Zhong M; Qiu L; Wu M; Weng X; Zhang W
    Clin Vaccine Immunol; 2010 Dec; 17(12):1985-90. PubMed ID: 20943878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
    Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
    Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study.
    Vincenti D; Carrara S; Butera O; Bizzoni F; Casetti R; Girardi E; Goletti D
    Clin Exp Immunol; 2007 Oct; 150(1):91-8. PubMed ID: 17680823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring of peptide-specific and gamma interferon-productive T cells in patients with active and convalescent tuberculosis using an enzyme-linked immunosorbent spot assay.
    Yang FF; Tu ZQ; Fang YM; Li Y; Peng Y; Dong T; Wang C; Lin SX; Zhan NY; Ma ZM; Feng YZ; Tan SY; Lai XM
    Clin Vaccine Immunol; 2012 Mar; 19(3):401-10. PubMed ID: 22237892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Gottschalk R; Nienhaus A
    Chest; 2009 Apr; 135(4):1010-1018. PubMed ID: 19017873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?
    Soysal A; Toprak D; Koc M; Arikan H; Akoglu E; Bakir M
    Nephrol Dial Transplant; 2012 Apr; 27(4):1645-50. PubMed ID: 21931124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children.
    Connell TG; Curtis N; Ranganathan SC; Buttery JP
    Thorax; 2006 Jul; 61(7):616-20. PubMed ID: 16601088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of a IFN-gamma assay in contact tracing for tuberculosis in a low-incidence, high immigration area.
    Janssens JP; Roux-Lombard P; Perneger T; Metzger M; Vivien R; Rochat T
    Swiss Med Wkly; 2008 Oct; 138(39-40):585-93. PubMed ID: 18853288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.